Lazard Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,930
Closed -$81K 2296
2024
Q1
$81K Sell
3,930
-297
-7% -$6.12K ﹤0.01% 1600
2023
Q4
$97K Sell
4,227
-431
-9% -$9.89K ﹤0.01% 1664
2023
Q3
$37K Hold
4,658
﹤0.01% 1939
2023
Q2
$40K Buy
+4,658
New +$40K ﹤0.01% 1896